Picture of Oncopeptides AB logo

ONCO — Oncopeptides AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Oncopeptides: Regulatory Approval To Start Window-Of-Opportunity Study In Glioblastoma

May 19 (Reuters) - Oncopeptides AB ONCO.ST:

ONCOPEPTIDES: ONCOPEPTIDES SECURES REGULATORY APPROVAL TO START WINDOW-OF-OPPORTUNITY STUDY IN GLIOBLASTOMA FROM NORWEGIAN AUTHORITIES

Source text: ID:nMFN61VGyZ

Further company coverage: ONCO.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Oncopeptides AB

See all news